We are Sorry, This Page doesn't Exist
Eli Lilly announces SURPASS-4 clinical trial meets primary, secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Orphazyme announces ORARIALS-01 trial did not meet primary, secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Orphazyme announces arimoclomol trial does not meet primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
NeuroRx announces Zyesami trial met primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Idera Pharmaceuticals announces ILLUMINATE-301 trial misses primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Agios Pharmaceuticals announces ACTIVATE-T trial meets primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eli Lilly announces BLAZE-1 trial meets primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eli Lilly announces Donanemab trial meets primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
aTyr Pharma announces ATYR1923 trial met its primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Soligenix announces DOM-INNATE trial did not meet primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Exelixis announces cabozantinib trial meets co-primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Astellas Pharma announces Xospata plus azacitidine trial misses primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioCardia announces modifications to primary endpoint for CardiAMP trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Spectrum amends ZENITH20 trial, announces strategy update for poziotinib program
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ocular Therapeutix announces Dextenza trial meets all primary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Viveve announces VIVEVE II trial did not meet primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aldeyra announces dry eye disease trial achieves primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eli Lilly announces ORIENT-11 trial met primary endpoint in interim analysis
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam announces ILLUMINATE-A trial meets primary, secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Evofem announces AMPREVENCE trial meets primary, secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»